Patents by Inventor Mark S. Chapman

Mark S. Chapman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEEP WATER ENCLOSURES FOR LIGHTING AND IMAGING
    Publication number: 20240147033
    Abstract: Enclosures for deep ocean or other high exterior pressure environment including a dome window with an angular measurement of between 164 and 178 degrees, a structure housing, a dome support ring, and a compliance material positioned between the dome support ring and housing are disclosed.
    Type: Application
    Filed: April 8, 2022
    Publication date: May 2, 2024
    Inventors: Eric M. Chapman, Mark S. Olsson, Jon E. Simmons
  • COMBINATIONS OF MEK INHIBITORS AND RAF KINASE INHIBITORS AND USES THEREOF
    Publication number: 20160271122
    Abstract: This invention concerns combinations of inhibitors of MEK, Raf protein kinases, and other kinases including VEGFR1-3 and PDGFR-?. This invention also concerns pharmaceutical compositions comprising the compounds described herein and methods of use of the compounds and compositions described herein, including the use in the treatment and/or prevention of cancer and other hyperproliferative disorders.
    Type: Application
    Filed: May 11, 2015
    Publication date: September 22, 2016
    Applicant: ARDEA BIOSCIENCES, INC.
    Inventors: Jeffrey N. MINER, Mark S. CHAPMAN, Barry QUART, Alex ADJEI, Chunrong YU
  • Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof
    Patent number: 9095581
    Abstract: This invention concerns combinations of inhibitors of MEK, Raf protein kinases, and other kinases including VEGFR1-3 and PDGFR-?. This invention also concerns pharmaceutical compositions comprising the compounds described herein and methods of use of the compounds and compositions described herein, including the use in the treatment and/or prevention of cancer and other hyperproliferative disorders.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: August 4, 2015
    Assignee: Ardea Biosciences, Inc.
    Inventors: Jeffrey N. Miner, Mark S. Chapman, Barry Quart, Alex Adjei, Chunrong Yu
  • TREATMENT OF PANCREATIC CANCER
    Publication number: 20120053211
    Abstract: The present invention relates to the field of oncology and relates to use of (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide or a pharmaceutically acceptable salt thereof or N-(4-(2-fluoro-4-iodophenylamino)-1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)cyclopropanesulfonamide or a polymorph thereof, or a pharmaceutically acceptable salt thereof, or pharmaceutical compositions comprising the same, for the preparation of a medicament for the treatment of pancreatic cancer.
    Type: Application
    Filed: March 11, 2010
    Publication date: March 1, 2012
    Applicant: ARDEA BIOSCIENCES, INC.
    Inventor: Mark S. Chapman